本页面由Tiger Trade Technology Pte. Ltd.提供服务

Opko Health

1.34
-0.0100-0.74%
盘后1.340.00000.00%19:56 EST
成交量:139.45万
成交额:187.43万
市值:10.29亿
市盈率:-5.41
高:1.36
开:1.33
低:1.33
收:1.35
52周最高:2.04
52周最低:1.11
股本:7.68亿
流通股本:3.51亿
量比:0.64
换手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-0.2475
每股收益(LYR):-0.0767
净资产收益率:-13.32%
总资产收益率:-6.15%
市净率:0.79
市盈率(LYR):-17.47

数据加载中...

2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/30

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/23

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/27

重要事件披露

Form 8-K - Current report
2024/07/26

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/17

重要事件披露

Form 8-K - Current report
2024/07/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/28

重要事件披露

Form 8-K - Current report